S. 2164
117th Congress
Senate
Lower Costs, More Cures Act of 2021
Official title: A bill to provide for certain reforms with respect to the Medicare program under title XVIII of the Social Security Act, and for other purposes.
Health
Business recordsCivil actions and liabilityCongressional oversightConsumer affairs
More subjectsShow fewer subjects
Department of Health and Human ServicesDigestive and metabolic diseasesDrug safety, medical device, and laboratory regulationDrug therapyExecutive agency funding and structureFood and Drug Administration (FDA)Fraud offenses and financial crimesGeneticsGovernment information and archivesGovernment studies and investigationsHealth care costs and insuranceHealth care coverage and accessHealth care qualityHealth personnelHealth promotion and preventive careHealth technology, devices, suppliesHome and outpatient careInflation and pricesManufacturingMarketing and advertisingMedicaidMedical researchMedicareOffice of the U.S. Trade RepresentativePrescription drugsProduct development and innovationPublic participation and lobbyingTrade agreements and negotiations
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 22, 2021
Read twice and referred to the Committee on Finance.
Jun 22, 2021
Introduced in Senate
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Latest action
Read twice and referred to the Committee on Finance.
Plain-English summary
Lower Costs, More Cures Act of 2021
This bill establishes and modifies several programs and requirements to address prescription drug prices, particularly in relation to Medicare and Medicaid.
Among other changes, the bill
- requires the Centers for Medicare & Medicaid Services to publish certain information, as reported by pharmacy benefit managers (PBMs), relating to generic dispensing rates, drug discounts and rebates, and payments between PBMs, health plans, and pharmacies;
- caps annual out-of-pocket spending under the Medicare prescription drug benefit;
- allows prescription drug plan sponsors under the Medicare prescription drug benefit to offer additional plans in a region;
- establishes requirements under the Medicaid Drug Rebate Program for certain gene therapies for which prices are indexed to achieved outcomes; and
- establishes the position of Chief Pharmaceutical Negotiator in the Office of the U.S. Trade Representative.
Related & companion bills
4
Bill text
1 version
- Introduced in Senate Formatted Text PDF Formatted XML
Committees of jurisdiction
1
Cite this page
U.S. Congress. (2026). S. 2164: Lower Costs, More Cures Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-S-2164/
"S. 2164: Lower Costs, More Cures Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-2164/.
S. 2164, 117th Cong. (2026), https://openamerica.io/bill/117-S-2164/.
[S. 2164: Lower Costs, More Cures Act of 2021](https://openamerica.io/bill/117-S-2164/)